Article thumbnail

Platelet-Activating Factor Antagonists Decrease Follicular Dendritic-Cell Stimulation of Human B Lymphocytes

By Isaac Halickman, Yolande Bastien, Qianli Zhuang, Monty B Mazer, Baruch Toledano and Bruce D Mazer

Abstract

Both B-lymphoblastoid cell lines and tonsillar B lymphocytes express receptors for platelet-activating factor (PAF). In lymph node germinal centres, B lymphocytes interact with follicular dendritic cells (FDCs), which present antigen-containing immune complexes to B lymphocytes. FDCs have phenotypic features that are similar to those of stromal cells and monocytes and may therefore be a source of lipid mediators. In this study, we evaluated the effects of the PAF antagonist WEB 2170 on the activation of tonsillar B lymphocytes by FDCs. FDCs were isolated from tonsils by Bovine Serum Albumin (BSA) gradient centrifugation. After being cultured for 6 to 10 days, they were incubated with freshly isolated B cells in the presence or absence of the specific PAF receptor antagonist WEB 2170. B-lymphocyte proliferation was assessed by [3H]-thymidine incorporation, and immunoglobulin (Ig) G and IgM secretion was assessed by enzyme-linked immunosorbent assay (ELISA). WEB 2170 (10-6 to 10-8 M) inhibited [3H]-thymidine incorporation by up to 35% ± 3%. Moreover, the secretion of IgG and IgM was inhibited by up to 50% by WEB 2170 concentrations ranging from 10-6 to 10-8 M. There was no evidence of toxicity by trypan blue staining, and the addition of WEB 2170 to B cells in the absence of FDCs did not inhibit the spontaneous production of IgG or IgM. The effect of the PAF antagonist is primarily on B lymphocytes, as reverse transcription polymerase chain reaction detected little PAF receptor messenger ribonucleic acid (mRNA) from FDCs. These data suggest that endogenous production of PAF may be important in the interaction of B lymphocytes with FDCs

Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2877066
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1995). A theory of follicular dendritic cell origin. Curr Top Microbiol Immunol
  2. (1995). Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1.
  3. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes.
  4. (1999). Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor. Cell Immunol
  5. (1999). Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes.
  6. (1994). Detection of the human platelet-activating factor receptor mRNA in human B lymphocytes by polymerase chain reaction on reverse transcripts (RT-PCR) [published erratum appears in Biochem Biophys Res Commun 1994;204:436]. Biochem Biophys Res Commun
  7. (1997). Direct cell/cell communication in the lymphoid germinal centre: connexin43 gap junctions functionally couple follicular dendritic cells to each other and to B lymphocytes.
  8. (1998). Dose dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes. J Allergy Clin Immunol
  9. Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response.
  10. (1998). Follicular dendritic cell (FDC) precursors in primary lymphoid tissues.
  11. (1996). Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro.
  12. (1995). Follicular dendritic cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisting endonuclease.
  13. (1992). Follicular dendritic cells: B-cell proliferation and maturation. Cancer Res
  14. (2001). Follicular dendritic cells: beyond the necessity of T-cell help. Trends Immunol
  15. (2000). Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev
  16. (1996). function and pathology of follicular dendritic cells. Pathol Int
  17. (1997). Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis.
  18. (1995). Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells.
  19. (1999). Human follicular dendritic cells inhibit superantigen-induced T-cell proliferation by distinct mechanisms.
  20. (1997). Human monocyte-derived and CD34+ cell-derived dendritic cells express functional receptors for platelet activating factor.
  21. Identification of a human follicular dendritic cell molecule that stimulates germinal center B cell growth.
  22. (2000). IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). Clin Exp Immunol
  23. (1995). Immunohistological detection of gap junctions in human lymphoid tissue: connexin43 in follicular dendritic and lymphoendothelial cells.
  24. (1986). Isolation of follicular dendritic cells from human tonsils and adenoids. VI. Analysis of prostaglandin secretion. Ann Inst Pasteur Immunol
  25. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients.
  26. MCP1 modulates chemotaxis by follicular lymphoma cells.
  27. (1995). Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
  28. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
  29. (1991). Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells.
  30. (1997). Plateletactivating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line.
  31. (1990). Plateletactivating factor enhances Ig production in B lymphoblastoid cell lines.
  32. (1990). Szakal AK. Follicular dendritic cells as accessory cells. Immunol Rev
  33. (1995). The human germinal centre cells, follicular dendritic cells and germinal centre T cells produce B cell-stimulating cytokines. Cytokine
  34. (1995). The monoclonal antibody FDC-M1 recognizes possible follicular dendritic cell precursors in the blood and bone marrow. Adv Exp Med Biol
  35. (1991). Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: present status. Lipids
  36. (1998). Tonsil stromal-cell lines expressing FDC-like properties: isolation, characterization, and interaction with B lymphocytes. Dev Immunol